Andrew Almond
Direktor/Vorstandsmitglied bei Imperagen Ltd.
Aktive Positionen von Andrew Almond
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Imperagen Ltd.
 Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Direktor/Vorstandsmitglied | 23.11.2021 | - |
Karriereverlauf von Andrew Almond
Ehemalige bekannte Positionen von Andrew Almond
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | - |
| Gründer | 01.01.2008 | - | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 14.10.2011 | - | |
| Gründer | 23.11.2009 | - | |
| Präsident | 23.11.2009 | 14.10.2011 |
Ausbildung von Andrew Almond
| The University of Edinburgh | Undergraduate Degree |
| The University of Manchester | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
| Israel | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Imperagen Ltd.
Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Commercial Services |
- Börse
- Insiders
- Andrew Almond
- Erfahrung
